🇺🇸 FDA
Pipeline program

GC1107

GC1107_P2/3

Phase 3 mab completed

Quick answer

GC1107 for Bacterial Infections is a Phase 3 program (mab) at Green Valley (Shanghai) Pharmaceuticals Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Green Valley (Shanghai) Pharmaceuticals Co.,
Indication
Bacterial Infections
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials